Table 1 Characteristics of dormancy candidates
| Â | CTC-positive | CTC-negative | Â |
|---|---|---|---|
(n = 40) | (n = 82) | P | |
Age, years | Â | Â | Â |
Median (range) | 52 (27-75) | 57 (31-71) | 0.133 |
| Â | N (%) | Â | |
Menopausal status | |||
Premenopausal  | 21 (52.5) | 28 (34.1) | 0.152 |
Postmenopausal | 18 (45) | 51 (62.2) | |
UN | 1 (2.5) | 3 (3.6) | |
HR status | |||
ER(+) and/or PR(+) | 26 (65) | 48 (58.5) | 0.212 |
ER(-)/PR(-) | 12 (30) | 24 (29.3) | |
UN | 2 (5) | 10 (12.2) | |
HER2 status | |||
HER2(+) | 9 (22.5) | 12 (14.6) | 0.252 |
HER2(-) | 29 (72.5) | 59 (72) | |
UN | 2 (5) | 11 (13.4) | |
Tumor size | |||
T1 | 10 (25) | 25 (30.5) | 0.418 |
T2 | 21 (52.5) | 45 (54.9) | |
T3 | 8 (20) | 8 (9.7) | |
UN | 1 (2.5) | 4 (4.8) | |
Grade | |||
I | 0 (0) | 1 (1.2) | 0.938 |
II | 18 (45) | 40 (48.8) | |
III | 17 (42.5) | 33 (40.2) | |
Lobular | 3 (7.5) | 5 (6) | |
UN | 2 (5) | 3 (3.6) | |
Number of positive nodes | |||
0 | 15 (37.5) | 33 (40.2) | 0.220 |
1-3 | 12 (30) | 33 (40.2) | |
≥4 | 12 (30) | 12 (14.6) | |
UN | 1 (2.5) | 4 (4.8) | |